Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

16.34 -0.16 (-0.97%)

Delayed Quote Updated: 9:46 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 06, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025

October 02, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

October 02, 2025

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Via StockStory

Topics World Trade

Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States

September 29, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today

September 25, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.5% in the afternoon session after the U.S. government opened an investigation into the national security implications of...

Via StockStory

Topics Economy World Trade

1 Growth Stock to Add to Your Roster and 2 We Brush Off

September 23, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

TNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law Firm

September 21, 2025

From The Schall Law Firm

Via Business Wire

Why Tandem Diabetes (TNDM) Stock Is Up Today

September 18, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery...

Via StockStory

Topics Artificial Intelligence Economy

1 Small-Cap Stock to Keep an Eye On and 2 We Turn Down

September 18, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels

September 16, 2025

From Tandem Diabetes Care

Via Business Wire

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

September 12, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Jim Cramer: This Is The Right Time To Buy This Energy Stock ↗

September 11, 2025

Mad Money's Jim Cramer looks at Phillips 66 and Intuitive Surgical, as well as Tandem Diabetes Care and Cintas.

Via Benzinga

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM

September 10, 2025

From Rosen Law Firm

Via Business Wire

Beyond The Numbers: 12 Analysts Discuss Tandem Diabetes Care Stock ↗

September 08, 2025

Via Benzinga

Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones

September 04, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

1 Volatile Stock with Exciting Potential and 2 We Avoid

September 04, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

3 Healthcare Stocks with Open Questions

August 27, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...

Via StockStory

Topics Stocks

Sirius XM, Lovesac, Rogers, Tandem Diabetes, and Altice Shares Are Falling, What You Need To Know

August 20, 2025

A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this...

Via StockStory

Topics Artificial Intelligence Economy World Trade

3 Unprofitable Stocks with Questionable Fundamentals

August 18, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

August 14, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 14, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 13, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Artificial Intelligence Economy

Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know

August 12, 2025

A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index...

Via StockStory

Topics Bonds Economy Stocks

TNDM Q2 Deep Dive: Margin Pressures and Strategic Shifts Offset Sales Growth

August 12, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.5% year on year to $240.7 million. The company...

Via StockStory

Top 3 Health Care Stocks That Are Preparing To Pump This Month ↗

August 11, 2025

Via Benzinga

3 Russell 2000 Stocks with Open Questions

August 08, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock ↗

August 07, 2025

Tandem Diabetes shares fall after a deeper loss, lower guidance, and a device recall tied to 700 adverse events and 59 injuries.

Via Benzinga

Traders are paying attention to the gapping stocks in Thursday's session. ↗

August 07, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.